collection
https://read.qxmd.com/read/25399890/-the-application-value-of-the-procalcitonin-clearance-rate-on-therapeutic-effect-and-prognosis-of-ventilator-associated-pneumonia
#21
JOURNAL ARTICLE
Abudusalamu Abula, Yi Wang, Long Ma, Xiangyou Yu
OBJECTIVE: To assess the disease severity and prognosis value by observing the kinetic change of serum procalcitonin (PCT) and PCT clearance rate (PCTc) in the patients with ventilator associated pneumonia (VAP). METHODS: A single-center prospective observational study was conducted. A total of 128 patients with VAP admitted into intensive care unit (ICU) of First Affiliated Hospital of Xinjiang Medical University from February 2012 to June 2014 were enrolled. The patients were divided into recovery group (n=88) and deterioration group (n=40) according to the therapeutic outcome...
November 2014: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
https://read.qxmd.com/read/25321910/association-between-vancomycin-minimum-inhibitory-concentration-and-mortality-among-patients-with-staphylococcus-aureus-bloodstream-infections-a-systematic-review-and-meta-analysis
#22
REVIEW
Andre C Kalil, Trevor C Van Schooneveld, Paul D Fey, Mark E Rupp
IMPORTANCE: Staphylococcus aureus bacteremia (SAB) is a worldwide problem. It is unclear whether higher-vancomycin minimum inhibitory concentration (MIC) is associated with mortality. This potential association has direct consequences for patients and public health. DATA SOURCES: PubMed, Embase, the Cochrane Library, Evidence-based Medicine BMJ, and the American College of Physicians Journal Club were searched from inception through April 2014. STUDY SELECTION: Studies reporting mortality and vancomycin MIC in patients with SAB were included...
October 15, 2014: JAMA
https://read.qxmd.com/read/25354514/the-clinical-spectrum-of-pulmonary-aspergillosis
#23
REVIEW
Chris Kosmidis, David W Denning
The clinical presentation of Aspergillus lung disease is determined by the interaction between fungus and host. Invasive aspergillosis develops in severely immunocompromised patients, including those with neutropenia, and increasingly in the non-neutropenic host, including lung transplant recipients, the critically ill patients and patients on steroids. A high index of suspicion is required in patients without the classical risk factors as early presentation is usually silent and non-specific, pyrexia uncommon and timely treatment is crucial for survival...
March 2015: Thorax
https://read.qxmd.com/read/25382700/efficacy-of-telavancin-a-lipoglycopeptide-antibiotic-in-experimental-models-of-gram-positive-infection
#24
REVIEW
Sharath S Hegde, James W Janc
Telavancin is a parenteral lipoglycopeptide antibiotic with a dual mechanism of action contributing to bactericidal activity against multidrug-resistant Gram-positive pathogens. It has been approved for the treatment of complicated skin and skin structure infections due to susceptible Gram-positive bacteria and hospital-acquired/ventilator-associated bacterial pneumonia due to Staphylococcus aureus when other alternatives are unsuitable. Telavancin has been demonstrated to be efficacious in multiple animal models of soft tissue, cardiac, systemic, lung, bone, brain and device-associated infections involving clinically relevant Gram-positive pathogens, including methicillin-resistant S...
December 2014: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/25382976/clavanin-bacterial-sepsis-control-using-a-novel-methacrylate-nanocarrier
#25
JOURNAL ARTICLE
Amanda C M Saúde, Alicia S Ombredane, Osmar N Silva, João A R G Barbosa, Susana E Moreno, Ana Claudia Guerra Araujo, Rosana Falcão, Luciano P Silva, Simoni C Dias, Octávio L Franco
Controlling human pathogenic bacteria is a worldwide problem due to increasing bacterial resistance. This has prompted a number of studies investigating peptides isolated from marine animals as a possible alternative for control of human pathogen infections. Clavanins are antimicrobial peptides isolated from the marine tunicate Styela clava, showing 23 amino acid residues in length, cationic properties, and also high bactericidal activity. In spite of clear benefits from the use of peptides, currently 95% of peptide properties have limited pharmaceutical applicability, such as low solubility and short half-life in the circulatory system...
2014: International Journal of Nanomedicine
https://read.qxmd.com/read/25245810/lactate-dehydrogenase-is-the-key-enzyme-for-pneumococcal-pyruvate-metabolism-and-pneumococcal-survival-in-blood
#26
JOURNAL ARTICLE
Paula Gaspar, Firas A Y Al-Bayati, Peter W Andrew, Ana Rute Neves, Hasan Yesilkaya
Streptococcus pneumoniae is a fermentative microorganism and causes serious diseases in humans, including otitis media, bacteremia, meningitis, and pneumonia. However, the mechanisms enabling pneumococcal survival in the host and causing disease in different tissues are incompletely understood. The available evidence indicates a strong link between the central metabolism and pneumococcal virulence. To further our knowledge on pneumococcal virulence, we investigated the role of lactate dehydrogenase (LDH), which converts pyruvate to lactate and is an essential enzyme for redox balance, in the pneumococcal central metabolism and virulence using an isogenic ldh mutant...
December 2014: Infection and Immunity
https://read.qxmd.com/read/25232870/streptococcus-pneumoniae-translocates-into-the-myocardium-and-forms-unique-microlesions-that-disrupt-cardiac-function
#27
JOURNAL ARTICLE
Armand O Brown, Beth Mann, Geli Gao, Jane S Hankins, Jessica Humann, Jonathan Giardina, Paola Faverio, Marcos I Restrepo, Ganesh V Halade, Eric M Mortensen, Merry L Lindsey, Martha Hanes, Kyle I Happel, Steve Nelson, Gregory J Bagby, Jose A Lorent, Pablo Cardinal, Rosario Granados, Andres Esteban, Claude J LeSaux, Elaine I Tuomanen, Carlos J Orihuela
Hospitalization of the elderly for invasive pneumococcal disease is frequently accompanied by the occurrence of an adverse cardiac event; these are primarily new or worsened heart failure and cardiac arrhythmia. Herein, we describe previously unrecognized microscopic lesions (microlesions) formed within the myocardium of mice, rhesus macaques, and humans during bacteremic Streptococcus pneumoniae infection. In mice, invasive pneumococcal disease (IPD) severity correlated with levels of serum troponin, a marker for cardiac damage, the development of aberrant cardiac electrophysiology, and the number and size of cardiac microlesions...
September 2014: PLoS Pathogens
https://read.qxmd.com/read/24105455/adjuvant-treatment-with-a-mammalian-target-of-rapamycin-inhibitor-sirolimus-and-steroids-improves-outcomes-in-patients-with-severe-h1n1-pneumonia-and-acute-respiratory-failure
#28
RANDOMIZED CONTROLLED TRIAL
Chun-Hua Wang, Fu-Tsai Chung, Shu-Min Lin, Shu-Yi Huang, Chun-Liang Chou, Kang-Yun Lee, Tzou-Yien Lin, Han-Pin Kuo
OBJECTIVES: Severe H1N1 pneumonia with acute respiratory failure results in infiltration of lungs due to the presence of hyperactive immune cells. Rapamycin and corticosteroids inhibit this immune response by blocking the activation of T and B cells. DESIGN: Open-label prospective randomized controlled trial. SETTING: A tertiary medical center, Chang Gung Memorial Hospital, located in Taiwan. PATIENTS: Between 2009 and 2011, of 4,012 H1N1-infected patients, 38 patients with severe H1N1 pneumonia and acute respiratory failure were enrolled...
February 2014: Critical Care Medicine
https://read.qxmd.com/read/25213272/combination-of-hypothiocyanite-and-lactoferrin-alx-109-enhances-the-ability-of-tobramycin-and-aztreonam-to-eliminate-pseudomonas-aeruginosa-biofilms-growing-on-cystic-fibrosis-airway-epithelial-cells
#29
JOURNAL ARTICLE
Sophie Moreau-Marquis, Bonita Coutermarsh, Bruce A Stanton
OBJECTIVES: Chelating iron may be a promising new therapy to eliminate Pseudomonas aeruginosa biofilms in the lungs of cystic fibrosis (CF) patients. Here, we investigate whether ALX-109 [a defined combination of an investigational drug containing lactoferrin (an iron-binding glycoprotein) and hypothiocyanite (a bactericidal agent)], alone and in combination with tobramycin or aztreonam, reduces P. aeruginosa biofilms grown on human CF airway epithelial cells. METHODS: P...
January 2015: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/25203869/novel-tests-for-diagnosis-of-invasive-aspergillosis-in-patients-with-underlying-respiratory-diseases
#30
COMPARATIVE STUDY
Juergen Prattes, Holger Flick, Florian Prüller, Christoph Koidl, Reinhard B Raggam, Michael Palfner, Susanne Eigl, Walter Buzina, Ines Zollner-Schwetz, Christopher R Thornton, Robert Krause, Martin Hoenigl
RATIONALE: Invasive pulmonary aspergillosis has been increasingly reported in nonneutropenic patients, including those with underlying respiratory diseases. OBJECTIVES: We compared the diagnostic performances of galactomannan, 1,3-β-D-glucan, and Aspergillus-specific lateral-flow device tests with that of conventional culture by using bronchoalveolar lavage fluid samples from patients with underlying respiratory diseases. METHODS: We analyzed 268 bronchoalveolar lavage samples from 221 patients with underlying respiratory diseases (and without hematologic malignancy or previous solid organ transplantation) that were collected for routine microbiological workup between February 2012 and May 2014 at the University Hospital of Graz, Austria...
October 15, 2014: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/25186256/cyanide-levels-found-in-infected-cystic-fibrosis-sputum-inhibit-airway-ciliary-function
#31
JOURNAL ARTICLE
Chandrika Nair, Amelia Shoemark, Mario Chan, Sarah Ollosson, Mellissa Dixon, Claire Hogg, Eric W F W Alton, Jane C Davies, Huw D Williams
We have previously reported cyanide at concentrations of up to 150 μM in the sputum of cystic fibrosis patients infected with Pseudomonas aeruginosa and a negative correlation with lung function. Our aim was to investigate possible mechanisms for this association, focusing on the effect of pathophysiologically relevant cyanide levels on human respiratory cell function. Ciliary beat frequency measurements were performed on nasal brushings and nasal air-liquid interface (ALI) cultures obtained from healthy volunteers and cystic fibrosis patients...
November 2014: European Respiratory Journal
https://read.qxmd.com/read/25169965/functional-synergy-of-%C3%AE-helical-antimicrobial-peptides-and-traditional-antibiotics-against-gram-negative-and-gram-positive-bacteria-in-vitro-and-in-vivo
#32
JOURNAL ARTICLE
Q Feng, Y Huang, M Chen, G Li, Y Chen
In this study, the antimicrobial activities based on the synergistic effects of traditional antibiotics (imipenem, cefepime, levofloxacin hydrochloride and vancomycin) and antimicrobial peptides (AMPs; PL-5, PL-31, PL-32, PL-18, PL-29 and PL-26), alone or in combination, against three Gram-positive bacteria (Staphylococcus aureus, Streptococcus pneumoniae and Staphylococcus epidermidis) and three Gram-negative bacteria (Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumoniae) were investigated. In addition, the antimicrobial activity that was based on the synergistic effects of levofloxacin hydrochloride and PL-5 against Staphylococcus aureus in vivo was explored in a mouse infection model...
January 2015: European Journal of Clinical Microbiology & Infectious Diseases
https://read.qxmd.com/read/25172637/lysophosphatidylcholine-as-a-prognostic-marker-in-community-acquired-pneumonia-requiring-hospitalization-a-pilot-study
#33
JOURNAL ARTICLE
W H Cho, H J Yeo, S H Yoon, S E Lee, D S Jeon, Y S Kim, S J Lee, E J Jo, J H Mok, M H Kim, K U Kim, K Lee, H K Park, M K Lee
Clinical prediction indicators such as the pneumonia severity index (PSI) and CURB-65 score are useful, but they are complex and often not followed. Therefore, biomarkers that improve hospital outcome predictions are emerging. This study evaluated the prognostic value of a new sepsis biomarker, serum lysophosphatidylcholine (LPC) concentrations, in community-acquired pneumonia (CAP) patients. We prospectively collected blood samples from emergency department CAP patients on days 1 and 7 (post-admission) and analyzed their plasma LPC concentrations...
February 2015: European Journal of Clinical Microbiology & Infectious Diseases
https://read.qxmd.com/read/25146717/long-term-mortality-after-community-acquired-pneumonia-impacts-of-diabetes-and-newly-discovered-hyperglycaemia-a-prospective-observational-cohort-study
#34
JOURNAL ARTICLE
Heikki O Koskela, Päivi H Salonen, Jarkko Romppanen, Leo Niskanen
OBJECTIVES: Community-acquired pneumonia is associated with a significant long-term mortality after initial recovery. It has been acknowledged that additional research is urgently needed to examine the contributors to this long-term mortality. The objective of the present study was to assess whether diabetes or newly discovered hyperglycaemia during pneumonia affects long-term mortality. DESIGN: A prospective, observational cohort study. SETTING: A single secondary centre in eastern Finland...
2014: BMJ Open
https://read.qxmd.com/read/25147670/correlation-of-multi-drug-resistance-integron-and-blaesbl-gene-carriage-with-genetic-fingerprints-of-extended-spectrum-%C3%AE-lactamase-producing-klebsiella-pneumoniae
#35
JOURNAL ARTICLE
Mitra Ashayeri-Panah, Mohammad Mehdi Feizabadi, Fereshteh Eftekhar
BACKGROUND: Some genetic and phenotypic variables are associated among distinct microbial populations. OBJECTIVES: The associations between multi-drug resistance (MDR) phenotypes, prevalence of antibiotic resistance integrons (ARIs), bla SHV, bla TEM and bla CTX-M gene carriage and genetic fingerprints of random amplified polymorphic DNA (RAPD), confirmed by pulsed field gel electrophoresis (PFGE), were investigated among extended-spectrum β-lactamases (ESBL)-producing nosocomial isolates of Klebsiella pneumoniae...
February 2014: Jundishapur Journal of Microbiology
https://read.qxmd.com/read/25123808/characterisation-of-a-collection-of-streptococcus-pneumoniae-isolates-from-patients-suffering-from-acute-exacerbations-of-chronic-bronchitis-in-vitro-susceptibility-to-antibiotics-and-biofilm-formation-in-relation-to-antibiotic-efflux-and-serotypes-serogroups
#36
JOURNAL ARTICLE
Nathalie M Vandevelde, Paul M Tulkens, Yvan Diaz Iglesias, Jan Verhaegen, Hector Rodriguez-Villalobos, Ivan Philippart, Julie Cadrobbi, Nathalie Coppens, An Boel, Kristien Van Vaerenbergh, Hugo Francart, Raymond Vanhoof, Giuseppe Liistro, Paul Jordens, Jean-Paul d'Odemont, Yvan Valcke, Franck Verschuren, Françoise Van Bambeke
The correlation between Streptococcus pneumoniae serotypes, biofilm production, antibiotic susceptibility and drug efflux in isolates from patients suffering from acute exacerbations of chronic bronchitis (AECB) remains largely unexplored. Using 101 isolates collected from AECB patients for whom partial (n=51) or full (n=50) medical details were available, we determined serotypes (ST)/serogroups (SG) (Quellung reaction), antibiotic susceptibility patterns [MIC (microdilution) using EUCAST and CLSI criteria] and ability to produce biofilm in vitro (10-day model; crystal violet staining)...
September 2014: International Journal of Antimicrobial Agents
https://read.qxmd.com/read/25129060/cd86-polymorphism-affects-pneumonia-induced-sepsis-by-decreasing-gene-expression-in-monocytes
#37
JOURNAL ARTICLE
Haihan Song, Lunxian Tang, Mingzheng Xu, Hongqiang Li, Shumin Xu, Guanggang Li, Xiaowei Bao, Bingke Sun, Tingting Cheng, Qian Yang, Jianwen Bai
Sepsis, a clinical syndrome occurring in patients following infection or injury, is a leading cause of morbidity and mortality worldwide. CD86 (B7-2) is a costimulatory molecule on antigen-presenting cells and plays critical roles in immune responses. In the current study, we investigated the association of two CD86 polymorphisms, rs1129055G/A and rs17281995G/C, with susceptibility to pneumonia-induced sepsis and examined the effects of these two polymorphisms on gene expression in monocytes. CD86 rs1129055G/A and rs17281995G/C were identified in 192 pneumonia-induced septic patients and 201 healthy controls...
April 2015: Inflammation
https://read.qxmd.com/read/25129577/aspiration-pneumonia-a-review-of-modern-trends
#38
REVIEW
David M DiBardino, Richard G Wunderink
PURPOSE: The purpose was to describe aspiration pneumonia in the context of other lung infections and aspiration syndromes and to distinguish between the main scenarios commonly implied when the terms aspiration or aspiration pneumonia are used. Finally, we aim to summarize current evidence surrounding the diagnosis, microbiology, treatment, risks, and prevention of aspiration pneumonia. MATERIALS AND METHODS: Medline was searched from inception to November 2013...
February 2015: Journal of Critical Care
https://read.qxmd.com/read/25130119/wandering-pneumonia-caused-by-dabigatran
#39
JOURNAL ARTICLE
Masakazu Kono, Kousuke Hirota, Ayako Yokoe, Chie Koumura, Toshihiko Sakai, Hirokazu Tojima
We herein describe the case of a 74-year-old man who experienced pulmonary consolidation and chest pain following administration of dabigatran, a novel oral anticoagulant. The consolidation settled spontaneously in another lung area, a condition sometimes referred to as "wandering pneumonia." Although we did not find specific pathological evidence of interstitial lung disease on transbronchial lung biopsy, a lung opacity spontaneously disappeared following discontinuance of dabigatran, and there was no recurrence...
2014: Internal Medicine
https://read.qxmd.com/read/25130297/a-randomized-controlled-clinical-trial-of-levofloxacin-750-mg-versus-500-mg-intravenous-infusion-in-the-treatment-of-community-acquired-pneumonia
#40
RANDOMIZED CONTROLLED TRIAL
Xu Zhao, Ju-Fang Wu, Qing-Yu Xiu, Chen Wang, De-Ping Zhang, Jian-An Huang, Can-Mao Xie, Sheng-Hua Sun, Xiao-Ju Lv, Bin Si, Zu-Ke Xiao, Ying-Yuan Zhang
The objective of this study was to compare the efficacy and safety of levofloxacin 750 mg for 5 days versus 500 mg for 7-14 days intravenous (IV) in the treatment of community-acquired pneumonia (CAP). This clinical trial was the first of its kind conducted in Chinese people and also in Asian population. A total of 241 were enrolled and randomized to 750 mg group (n = 121) or 500 mg (n = 120) group from 10 study centers. The median treatment duration was 5.0 days in 750 mg and 9.0 days in 500 mg group. The median total dose was 3750 mg in 750 mg and 4500 mg in 500 mg group...
October 2014: Diagnostic Microbiology and Infectious Disease
label_collection
label_collection
2505
2
3
2014-08-23 21:28:14
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.